Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 705 results for "erbitux"

Eli Lilly : Trademark Application for "ERBITUX CETUXIMAB" Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ERBITUX CETUXIMAB" by Robert E. Lee , Jr., representing ... 4 Traders, 1 month ago

Antibodies in Oncology Drug Pipeline Update 2014

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of ...
 Global Information Inc1 month ago
Securities Technology Monitor

Advaxis Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer

Former Executive Director, Section Head Oncology Clinical Development at Merck & Co., Inc. and Director of Erbitux Medical Strategy at Bristol-Myers Squibb to Oversee Advaxis's Clinical Programs PRINCETON, N.J., Oct. 20, 2014 (GLOBE NEWSWIRE) -- ...
 Securities Technology Monitor2 months ago Advaxis, Inc. Appoints David J. Mauro, M.D., Ph.D., As Chief Medical Officer  FierceBiotech1 month ago Advaxis, Inc. Appoints As Chief Medical Officer  BioSpace2 months ago Advaxis : Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer  4 Traders2 months ago

Sorrento and Conkwest Announce Exclusive Global Collaboration

Developing Next Generation Cancer Immunotherapy with "Off-the-Shelf" Chimeric Antigen Receptor-Tumor Attacking Natural Killer (CAR-TNK) Cell Lines SAN DIEGO and CARDIFF-BY-THE-SEA, Calif., Dec. 19, 2014 /PRNewswire/ --Sorrento Therapeutics, Inc.
 Stockwatch1 day ago Sorrento Therapeutics, Inc. And Announce Exclusive Global Collaboration  BioSpace1 day ago SORRENTO THERAPEUTICS : and Conkwest Announce Exclusive Global Collaboration  4 Traders1 day ago
Pharma Letter

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 202018-12-2014

The Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from $1.9 billion in 2013 to $2.9 billion by 2020, at a compound annual growth rate (CAGR) of 6.5%, says a new report. This expansion, occurring ...
 Pharma Letter2 days ago Colorectal Cancer Drug Pipeline Update 2014  Global Information Inc1 month ago Alchemia Shares Plummet On Failed Colorectal Cancer Trial  BioSpace1 month ago Alchemia (ACL.AX) Shares Plummet On Failed Colorectal Cancer Trial 10/27/2014  ClinicSpace1 month ago

Trovagene Releases Clinical Study Results for Detection and Monitoring of KRAS Mutations in ...

Trovagene Inc., a developer of cell-free molecular diagnostics, recently announced clinical study results highlighting the company's ability to detect and quantitate KRAS mutations in blood and urine samples from patients with advanced colorectal ...
 Advance for Administrators of the Laboratory2 days ago TROVAGENE : Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients  4 Traders4 weeks ago TrovaGene, Inc. Releases Clinical Study Results For The Detection And Monitoring Of KRAS Mutations In Circulating Tumor DNA Of Colorectal Cancer Patients  BioSpace4 weeks ago
Jutia Group

Market Update: Bristol-Myers Squibb Company (NYSE:BMY) Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2014 on January 27

[Business Wire] Bristol-Myers Squibb Company will announce results for the fourth quarter and full year of 2014 on Tuesday, January 27, 2015. During a conference call at 9 a.m. EST on J Read more on this. Bristol-Myers Squibb Company (BMY) , ...
 Jutia Group3 days ago Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) Multiple Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 56th Annual American Society for Hematology (ASH) Meeting  Jutia Group1 month ago Bristol-Myers product revenues off 6%, earnings guidance lowered  Seeking Alpha1 month ago
Motley Fool

The Next Big Pharma Buyout

In a bid to offset the risk of patent expiration, drugmakers spend billions of dollars every year on acquisitions to bolster drug pipelines and boost sales. But just because we know that Big Pharma has a penchant for purchases doesn't mean we know ...
 Motley Fool1 week ago This Could Be the Next Big Pharma Buyout  Nasdaq1 week ago

New Study : Global and China Monoclonal Antibody Industry Report Share 2014-2019

Most up-to-date research on "Global and China Monoclonal Antibody Industry Report, 2014-2019" to its huge collection of research reports. Albany, NY -- (ReleaseWire) -- 12/12/2014 -- Despite world-wide economic downturn and great changes in ...
 Digital Journal1 week ago Monoclonal Antibody Market: Global and China Market Analysis, Industry Size, Share, Growth, Trends and Forecsat Report 2014-2019 Available Online by MarketResearchReports  Digital Journal1 month ago Research and Markets Adds Report: Global and China Monoclonal Antibody Industry Report,-2019  Individual.com1 month ago Global and China Monoclonal Antibody Industry Report 2014-2019  PharmiWeb1 month ago

Patient access schemes lack transparency

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because of their lack of transparency, say academics. An analysis by researchers from University College London ...
 Pharmafocus1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less